Laborie inks $465M deal to buy post-childbirth device from Organon

Organon tripled sales of the bleeding-control system from 2022 to 2024 and is on track to grow sales again this year.

Source: https://www.medtechdive.com/news/Laborie-465M-deal-buy-Jada-post-childbirth-device-Organon/805097/